Dr. P. A. Jiwani
MBBS, MD, Dip Cardiology, DNB (Cardiology), FESC
Cardiologist
Specializations
- Cardiologist
- Interventional Cardiologist
Qualifications
- MBBS - Government Medical College and Hospital - 1977 - Nagpur - India
- MD - General Medicine - Government Medical College and Hospital - 1981 - Nagpur - India
- Diploma - Cardiology - University of London Royal Postgraduate Medical School Hamar Smith Hospital - 1989 - London - England
- DNB - Cardiology - NIMS - 1992 - Hyderabad
- FESC - European Society of Cardiology - 2016 - Sophia Antipolis - France
Experiences
- President - AP Cardiology Society of India Vijayawada - India - 2007 - 2008
- Advisory Board Member KIMS - Secunderabad - Hyderabad
- Medical Specialist and Cardiologist Govt. General Hospital Ministry of Health - Saudi Arabia
- Asst. Professor - Cardiology NIMS - Hyderabad
- Independent Executive Director Vijayasree Organics Ltd - Hyderabad.
- Senior Consultant and Interventional Cardiologist KIMS - Begumpet - Currently Working
- Consultant and Interventional Cardiologist MED9 Health Care - Banjara Hills - Currently Working
Registrations
- 78672 Andhra Pradesh Medical Council 2013
Memberships
- Cardiology Society of India
- Indian Medical Association (IMA)
- Academy of Medical Sciences - India
Paper Presentations
- Publications:
- LIFENOX STUDY - International multicenter - randomized- double blind study to compare the overall mortality in acutely ill
- XIENCE V Registry - Xience Everolimus Eluting Coronary Stent System (EECSS) India Post Marketing Registry.
- PLATO STUDY - A Randomized- Double blind - parallel group - phase 3 - Efficacy and safety study of AZD6 140 Compared with Clopidogrel for prevention of vascular events in patients with Non –ST or ST elevation Acute Coronary Syndrome (ACS)
- OASIS -7 (CURRENT) STUDY) - Randomized - Multinational - double blind study - comparing a high loading dose regimen of Clopidogrel versus standard dose in patient with Unstable Angina or myocardial infarction managed with an early invasive strategy - Oasis -7 Study.
- PLATO STUDY - A Randomized- Double blind - parallel group- phase 3 - Efficacy and safety study of AZD6 140 Compared with Clopidogrel for prevention of vascular events in patients with Non-ST or ST elevation Acute Coronary Syndrome (ACS)
- MICHELANGELO OASIS - 6 (STEMI) STUDY) - an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.
- OASIS -7 (CURRENT) STUDY) - Randomized - Multinational - double blind study - comparing a high loading dose regimen of Clopidogrel versus standard dose in patient with Unstable Angina or myocardial infarction managed with an early invasive strategy - Oasis -7 Study.
- LIFENOX STUDY - International multicenter - randomized- double blind study to compare the overall mortality in acutely ill medical patients treated with enoxaparin versus placebo in addition to Graduated Elastic Stockings. MICHELANGELO OASIS - 6 (STEMI) STUDY) - an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.
Report an error
Practice Locations
1-8-31/1, Minister Rd
Krishna Nagar Colony
Begumpet, Secunderabad
Fee : ₹ 750
Get direction
OP Timings
| Mon - Sat | 10:00 am - 04:00 pm |
8-3-833/60
Srinagar Colony Main Rd, Sagar Society
Kamalapuri Colony
Banjara Hills, Hyderabad.
Fee : ₹ 700
Get direction
OP Timings
| - | |
No Reviews Found!
Write a review for Dr. P. A. Jiwani
Related searches
Popular Searches
skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.
skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.
West Bengal
See More On Skedoc
Want to be notified when our article is published? Enter your email address and name below to be the first to know
Login with Facebook
Login with Gmail Or
Already have an account? Login here